Crossmark Global Holdings, Inc. Haemonetics Corp Transaction History
Crossmark Global Holdings, Inc.
- $5.49 Billion
- Q4 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 5,884 shares of HAE stock, worth $371,809. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,884
Previous 6,514
9.67%
Holding current value
$371,809
Previous $524,000
12.4%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding HAE
# of Institutions
348Shares Held
51.8MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$327 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$268 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$161 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.24B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...